The COVID-19 pandemic has brought aerosol-related diseases to the forefront of the healthcare conversation. Health systems and GI practices alike continue to grapple with the best ways to diagnose and treat patients in a specialized, affordable, and safe manner. As telehealth and virtual visits become a mainstay in the healthcare delivery model, so must the consideration of at-home diagnostics, especially for aerosol-generating procedures like GI breath testing.
Keep Reading
Add A Comment